Annual EBITDA
$503.80M$72.40M-12.56%
Summary
- Current Value
- As of today, BIO annual EBITDA is $503.80M, down -12.56% on
- Historical Performance
- BIO annual EBITDA is down -32.07% over the past 3 years, and up +17.58% over the past 5 years
- All-Time High Comparison
- BIO annual EBITDA is currently -32.07% below its historical high of $741.64M set on
- 3-Year Low Comparison
- BIO annual EBITDA is at its 3-year low
- Sector Comparison
- BIO annual EBITDA is higher than 91.43% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $503.80M | -12.6% | -32.1% | +17.6% | +49.7% | |
| Quarterly EBITDA | $120.60M | -15.9% | -13.1% | -20.7% | +19.3% | |
| TTM EBITDA | $489.90M | -9.4% | -28.6% | -1.6% | +31.0% | |
| Price | $324.09 | -5.9% | -22.6% | -47.8% | +208.4% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $2.57B | -3.9% | -12.2% | +11.0% | +43.8% | |
| Annual EPS | -$65.36 | -199.6% | -146.4% | -212.2% | -1357.0% | |
| Annual EBIT | $311.00M | -19.0% | -44.9% | +22.5% | +32.5% | |
| Annual Net Income | -$1.84B | -189.4% | -143.3% | -204.9% | -1336.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $656.52M | N/A | -23.3% |
| 5Y | $741.64M | -32.1% | |
| All | $741.64M | -32.1% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $503.80M | at low | |
| 5Y | $503.80M | at low | |
| All | $1.29M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of BIO?
As of today, BIO annual EBITDA is $503.80M
What is 1-year change in BIO annual EBITDA?
BIO annual EBITDA is down -12.56% year-over-year
What is 3-year change in BIO annual EBITDA?
BIO annual EBITDA is down -32.07% over the past 3 years
How far is BIO annual EBITDA from its all-time high?
BIO annual EBITDA is currently -32.07% below its historical high of $741.64M set on December 31, 2021
How does BIO annual EBITDA rank versus sector peers?
BIO annual EBITDA is higher than 91.43% of companies in Healthcare sector
When is BIO next annual earnings release?
The next annual earnings release for BIO is on
Quarterly EBITDA
$120.60M$9.50M-7.30%
Summary
- Current Value
- As of today, BIO quarterly EBITDA is $120.60M, down -7.30% on
- Historical Performance
- BIO quarterly EBITDA is down -15.94% year-over-year, and down -13.08% over the past 3 years
- All-Time High Comparison
- BIO quarterly EBITDA is currently -44.92% below its historical high of $218.96M set on
- 3-Year Low Comparison
- BIO quarterly EBITDA is +20.83% above its 3-year low of $99.81M reached on
- Sector Comparison
- BIO quarterly EBITDA is higher than 89.88% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $120.60M | -7.3% | -15.9% | -13.1% | -20.7% | |
| Annual EBITDA | $503.80M | – | -12.6% | -32.1% | +17.6% | |
| TTM EBITDA | $489.90M | -4.5% | -9.4% | -28.6% | -1.6% | |
| Price | $324.09 | +7.0% | -5.9% | -22.6% | -47.8% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $653.00M | +0.2% | +0.5% | -4.1% | +0.9% | |
| Quarterly EPS | -$12.70 | -208.8% | -154.4% | -131.9% | -129.1% | |
| Quarterly EBIT | $66.40M | -16.5% | -29.6% | -29.8% | -39.3% | |
| Quarterly Net Income | -$341.90M | -207.6% | -152.3% | -110.0% | -126.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $134.10M | N/A | -10.1% |
| 3Y | $160.84M | N/A | -25.0% |
| 5Y | $218.96M | -44.9% | |
| All | $218.96M | -44.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $105.10M | +14.8% | |
| 3Y | $99.81M | +20.8% | |
| 5Y | $99.81M | +20.8% | |
| All | -$125.80M | +195.9% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of BIO?
As of today, BIO quarterly EBITDA is $120.60M
What is BIO quarterly EBITDA most recent change?
BIO quarterly EBITDA was down -7.30% on September 30, 2025
What is 1-year change in BIO quarterly EBITDA?
BIO quarterly EBITDA is down -15.94% year-over-year
How far is BIO quarterly EBITDA from its all-time high?
BIO quarterly EBITDA is currently -44.92% below its historical high of $218.96M set on March 31, 2021
How does BIO quarterly EBITDA rank versus sector peers?
BIO quarterly EBITDA is higher than 89.88% of companies in Healthcare sector
When is BIO next earnings release?
The next earnings release for BIO is on
TTM EBITDA
$489.90M$22.87M-4.46%
Summary
- Current Value
- As of today, BIO TTM EBITDA is $489.90M, down -4.46% on
- Historical Performance
- BIO TTM EBITDA is down -9.44% year-over-year, and down -28.57% over the past 3 years
- All-Time High Comparison
- BIO TTM EBITDA is currently -38.24% below its historical high of $793.29M set on
- 3-Year Low Comparison
- BIO TTM EBITDA is at its 3-year low
- Sector Comparison
- BIO TTM EBITDA is higher than 90.24% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $489.90M | -4.5% | -9.4% | -28.6% | -1.6% | |
| Annual EBITDA | $503.80M | – | -12.6% | -32.1% | +17.6% | |
| Quarterly EBITDA | $120.60M | -7.3% | -15.9% | -13.1% | -20.7% | |
| Price | $324.09 | +7.0% | -5.9% | -22.6% | -47.8% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $2.56B | +0.1% | -0.9% | -8.8% | +7.5% | |
| TTM EPS | -$24.31 | -307.1% | +11.1% | +87.9% | -120.8% | |
| TTM EBIT | $287.60M | -8.9% | -16.5% | -41.8% | -11.5% | |
| TTM Net Income | -$675.90M | -311.8% | +13.2% | +88.8% | -119.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $529.56M | -7.5% | |
| 3Y | $668.99M | N/A | -26.8% |
| 5Y | $793.29M | -38.2% | |
| All | $793.29M | -38.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $489.90M | at low | |
| 3Y | $489.90M | at low | |
| 5Y | $489.90M | at low | |
| All | -$55.90M | +976.4% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of BIO?
As of today, BIO TTM EBITDA is $489.90M
What is BIO TTM EBITDA most recent change?
BIO TTM EBITDA was down -4.46% on September 30, 2025
What is 1-year change in BIO TTM EBITDA?
BIO TTM EBITDA is down -9.44% year-over-year
How far is BIO TTM EBITDA from its all-time high?
BIO TTM EBITDA is currently -38.24% below its historical high of $793.29M set on September 30, 2021
How does BIO TTM EBITDA rank versus sector peers?
BIO TTM EBITDA is higher than 90.24% of companies in Healthcare sector
When is BIO next earnings release?
The next earnings release for BIO is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- BIO Official Website www.bio-rad.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/12208/000001220825000077/0000012208-25-000077-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/12208/000001220825000007/0000012208-25-000007-index.htm
- BIO Profile on Yahoo Finance finance.yahoo.com/quote/BIO
- BIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bio